Cargando…
Immune-related biomarkers in triple-negative breast cancer
Breast cancer is a commonly diagnosed female cancer in the world. Triple-negative breast cancer (TNBC) is the most dangerous and biologically aggressive subtype in breast cancer which has a high mortality, high rates of relapse and poor prognosis, representing approximately 15–20% of breast cancers....
Autores principales: | Zhang, Juan, Tian, Qi, Zhang, Mi, Wang, Hui, Wu, Lei, Yang, Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8213542/ https://www.ncbi.nlm.nih.gov/pubmed/33837508 http://dx.doi.org/10.1007/s12282-021-01247-8 |
Ejemplares similares
-
Development of an immune-related prognostic biomarker for triple-negative breast cancer
por: Zhang, Yan, et al.
Publicado: (2022) -
A novel model associated with tumor microenvironment on predicting prognosis and immunotherapy in triple negative breast cancer
por: Zhang, Juan, et al.
Publicado: (2023) -
Immune Checkpoint Inhibitors in Triple Negative Breast Cancer: The Search for the Optimal Biomarker
por: Qureshi, Sadaf, et al.
Publicado: (2022) -
LncRNAs as new biomarkers to differentiate triple negative breast cancer from non-triple negative breast cancer
por: Lv, Mingming, et al.
Publicado: (2016) -
Extracellular Vesicles in Triple–Negative Breast Cancer: Immune Regulation, Biomarkers, and Immunotherapeutic Potential
por: Das, Kaushik, et al.
Publicado: (2023)